New testosterone injection could help teen boys with delayed puberty
Disease control
Recruiting now
This phase 3 trial is testing XYOSTED, a testosterone injection, in 100 adolescent males who lack or have low testosterone due to hypogonadism. The study lasts 52 weeks, with a 24-month safety follow-up, and aims to see if the treatment can safely induce or continue puberty. Part…
Phase: PHASE3 • Sponsor: Halozyme Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC